SCHEMBL6604920

SCHEMBL6604920

COC(=O)CCc1oc(=O)[nH]c1-c1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.46
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 4/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
LMNA P02545 3/20 0.38
MAPT P10636 3/20 0.37
TP53 P04637 1/20 0.35
MDM2 Q00987 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7462336 0.93 EGFR (0.41) EGFRCYP11B1CYP11B2ALDH1A1HPGD
SCHEMBL5212080 0.87 MAPK14 (0.42) EGFRCYP11B1CYP11B2ALDH1A1KDM4E
SCHEMBL5212912 0.87 ALDH1A1 (0.42) CYP11B1CYP11B2ALDH1A1KDM4EHPGD
SCHEMBL5212142 0.87 KDM4E (0.45) EGFRALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL1361195 0.86 EGFR (0.41) EGFRALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL5207996 0.85 EGFR (0.45) EGFRALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL1361189 0.84 APOL1 (0.39) EGFRALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL1362553 0.73 CYP11B1 (0.43) EGFRCYP11B1CYP11B2ALDH1A1KDM4E
SCHEMBL10833120 0.72 ALDH1A1 (0.43) EGFRCYP11B1CYP11B2ALDH1A1KDM4E
SCHEMBL6603521 0.71 CYP11B1 (0.41) EGFRCYP11B1CYP11B2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699995-B1 ALKYLATION AT 5-POSITION OF OXAZOLE BY REACTION WITH UNSATURATED COMPOUND IN PRESENCE OF ACID OR BASE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
EP-1219610-B1 PROCESS FOR THE PREPARATION OF OXAZOLE DERIVATIVES TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-02-25 EP disclosed
US-6498179-B1 SUCH AS 4-(4-CHLOROPHENYL)-5-(3-(2-METHOXYPHENOXY)PROPYL)-2-(2-METHYL-1 -IMIDAZOLYL)OXAZOLE; INSULIN SECERTION PROMOTING AND BLOOD SUGAR DEPRESSING EFFECT; DIABETES; LOW TOXICITY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-12-24 US disclosed
EP-0891340-B1 OXAZOLE DERIVATIVES, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-11-13 EP disclosed
EP-1219610-A1 PROCESS FOR THE PREPARATION OF OXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2002-07-03 EP disclosed
US-6177452-B1 ANTIDIABETIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-01-23 US disclosed
EP-0891340-A1 OXAZOLE DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1999-01-20 EP disclosed
WO-1997036882-A1 OXAZOLE DERIVATIVES, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-09 WO disclosed